Navigation Links
Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
Date:12/13/2011

THOUSAND OAKS, Calif., Dec. 13, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that data from several key Nplate® (romiplostim) studies were presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH), Dec. 10-13, 2011, in San Diego. Of note, final results from the international, Phase 3, open-label, single-arm '209 study evaluating the safety and efficacy of Nplate in adults with primary immune thrombocytopenia (ITP) demonstrated that Nplate induced a rapid platelet response in adult ITP patients with low platelet counts or bleeding symptoms and maintained a consistent safety profile (Abstract No. 3279).

In the study, incidence and type of adverse events (AEs) in patients treated with Nplate were consistent with those reported in previous studies. The most common side effects included headache, arthralgia and fatigue.

Approximately 90 percent of patients achieved each of the platelet response definitions, regardless of splenectomy status. Median time to response was one to two weeks. Over the course of the study, a doubling of the platelet count to greater than or equal to 50,000 platelets per microliter was achieved by 91 percent of patients who received Nplate. A platelet count increase of greater than or equal to 20,000 platelets per microliter from baseline was achieved by 93 percent of patients who received Nplate.

"We are very pleased to present the final results from the largest prospective study of Nplate in adult patients with primary ITP, which highlight Nplate's ability to successfully treat these patients," said Sean E. Harper, M.D., senior vice president of Global Development and chief medical officer at Amgen. "Additional data presented at the meeting in other disease states help further elucidate the safety and efficacy profile of Nplate. Collectively, these data help
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
2. Amgen’s Third Quarter 2011 Revenue and Adjusted Earnings Per Share (EPS) Each Increased 3 Percent to $3.9 Billion and $1.40
3. Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations
4. Amgen Appoints Robert A. Bradway to the Companys Board of Directors
5. Amgen Announces 2011 Fourth Quarter Dividend
6. Amgen to Present at the UBS Global Life Sciences Conference
7. Amgen Staff Volunteer Efforts Result in $5,000 For Each of Their Favorite Nonprofits
8. Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign
9. Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign
10. Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research Meeting
11. Amgen Submits Application to Expand Indication for XGEVA® (Denosumab) to Prevent or Delay Spread of Prostate Cancer to the Bone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... July 03, 2015 , ... ... applications such as animal waste reduction, bioremediation, wastewater treatment, aquaculture and grease, ... announced today that it will be showcasing, ManureMagic™, its industry-leading product for ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Alexander Group, a 30-year ... industries alike-- typically known for its consummate professionalism-- embarks each year in a ... break from their day jobs. , "Our motto has always been work hard ...
(Date:7/3/2015)... , July 3, 2015 ... 22 september 2015 på  http://www.openinnovationinscience.at till ... in Science" som hålls i ... färsk undersökning med internationella forskare och vetenskapsmän ... är hälsovetenskapens två största utmaningar bristen på ...
(Date:7/3/2015)...  Pomerantz LLP announces that a class action lawsuit ... the "Company")(NYSE: PBYI ) and certain of its ... Court, Central District of California , ... class consisting of all persons or entities who purchased ... 2015 inclusive (the "Class Period").  This class action seeks ...
Breaking Biology Technology:DryLet to Highlight Benefits of Patented ManureMagic™ at North American Manure Expo in Chambersburg, PA July 14-15, 2015 2The Alexander Group Declares Their Independence with a Bit of Levity 2Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 4
... and Lehigh University has reported a breakthrough in the quest ... in electronics, medicine and other applications. In an article ... the group says it has developed a DNA-based method that ... CNTs are long, narrow cylinders of graphite with a ...
... (OTC Bulletin Board: MNCN), an innovative, global wellness solutions company, ... the OTC Bulletin Board under the symbol "MNCN." The Company,s ... , "The move to the OTC Bulletin Board will ... investors and help improve our trading liquidity," said Patrick Sheridan, ...
... CHENGDU, China, July 8 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical ... and supplier of,modernized traditional Chinese medicine ("TCM") based in Chengdu, ... its common stock shareholders.,The dividend of $0.025 will be paid ... actual distribution occurring on or about September 10, 2009. , ...
Cached Biology Technology:Researchers enlist DNA to bring carbon nanotubes' promise closer to reality 2Researchers enlist DNA to bring carbon nanotubes' promise closer to reality 3Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders 2
(Date:6/17/2015)... , June 17, 2015  Crossmatch™, a leading ... that its U.are.U ® 4500 fingerprint readers ... Eateries, Inc., a San Jose, ... to increase security, improve accountability and reduce fraud ... instant, non-repudiable identity confirmation for employee sign in ...
(Date:6/16/2015)... Fingerprint Cards (FPC) raises the revenue ... amount to at least 340 MSEK to that it will ... in market growth and orders received the revenue guidance for ... for 2015 will exceed 1,500 MSEK to an updated guidance ... Due to receipt of orders of touch fingerprint ...
(Date:6/12/2015)... , June 12, 2015  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... its patent to electronically capture, analyze and identify ... facial recognition methods. This system can: ... by an enrollment and subsequent sign-on process is ...
Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2
... been identified for the chronic bowel condition Crohn,s Disease, in ... today in The American Journal of Human Genetics , ... and mapping gene locations for complex inherited diseases. Using this ... of additional genes for Crohn,s Disease, making a total of ...
... types of disturbances to the seafloor can affect ... ecosystem functions they provide us (e.g. nutrient cycling, ... the Marine Research Centre of the Finnish Environment ... of invertebrates, critical in both the recovery process ...
... Asia-Pacific gathered today for the opening of the International ... at the Kuala Lumpur Convention Centre until December 16, ... Malaysia, YB Datuk Rosnah bt. Hj. Abd. Rashid Shirlin, ... Excellency Tun Dato, Seri Utama (Dr.) Haji Abdul Rahman ...
Cached Biology News:More than 200 genes identified for Crohn's Disease 2Measuring dispersal -- how well are soft-sediment invertebrate communities connected on the seafloor? 2IOF Asia-Pacific Meeting presents new research and advances in osteoporosis management 2IOF Asia-Pacific Meeting presents new research and advances in osteoporosis management 3
...
... from different Cynomolgus monkey normal tissues ... available upon request. Customers can ... whole set, and pay 70% of ... Dr. P Set products are for ...
... consists of AmnioMAX-C100 Basal ... and AmnioMAX-C100 Supplement (Cat. ... complete with antibiotics and ... requires no further supplementation ...
Anti-Dynamin Monoclonal Antibody Description: 100 g Research Focus: neuroscience Storage: -20C Shipping Temperature: 4C...
Biology Products: